CYP3A4
Selected indexed studies
- CYP3A4 and CYP3A5: the crucial roles in clinical drug metabolism and the significant implications of genetic polymorphisms. (PeerJ, 2024) [PMID:39650550]
- CYP3A4-mediated pharmacokinetic interactions in cancer therapy. (Curr Drug Metab, 2014) [PMID:25705904]
- Transcriptional regulation of CYP3A4 by nuclear receptors in human hepatocytes under hypoxia. (Drug Metab Rev, 2020) [PMID:32270716]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- CYP3A4 and CYP3A5: the crucial roles in clinical drug metabolism and the significant implications of genetic polymorphisms. (2024) pubmed
- CYP3A4-mediated pharmacokinetic interactions in cancer therapy. (2014) pubmed
- Transcriptional regulation of CYP3A4 by nuclear receptors in human hepatocytes under hypoxia. (2020) pubmed
- The Mechanism-Based Inactivation of CYP3A4 by Ritonavir: What Mechanism? (2022) pubmed
- Decoding the selective chemical modulation of CYP3A4. (2025) pubmed
- A patent review of CYP3A4 inhibitors (2018 - present). (2025) pubmed
- Interplay of Vitamin D and CYP3A4 Polymorphisms in Endocrine Disorders and Cancer. (2022) pubmed
- CYP3A4*22 and bleeding risk in ticagrelor users. (2024) pubmed
- Functional gene variants of CYP3A4. (2014) pubmed
- CYP3A4*22: promising newly identified CYP3A4 variant allele for personalizing pharmacotherapy. (2013) pubmed